PREVENÇÃO E RASTREIO DO CÂNCER DE COLO DE ÚTERO
Open Access
- 1 January 2024
- journal article
- research article
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 6 (1) , 1131-1138
Abstract
Cervical cancer (CC) is the fourth most common neoplasm and the fourth leading cause of cancer death among women worldwide, being responsible for approximately 570,000 new cases and 311,000 deaths in 2018. The objective of this article is to identify recent and relevant information available in the literature on CC prevention and screening. This is an integrative review with articles dated between 2018 and 2013 in the Lilacs, Scielo and Google Scholar databases. Vaccination against (HPV) is an important public health strategy to prevent CC. The vaccine offers a powerful tool to substantially reduce the burden of CC worldwide. The fundamental principle of cancer screening is the detection of the disease at an early, curable stage in the asymptomatic and apparently healthy population. The goal of uterine cancer screening is to detect high-grade lesions in asymptomatic women, treat them, and prevent progression to invasive disease. Prevention and screening strategies are excellent ways to mitigate the incidence and mortality of women with CC worldwide. However, this care is less in socioeconomically unfavorable countries, black women and women who live in rural areas. O câncer do colo do útero (CCU) é a quarta neoplasia mais comum e a quarta principal causa de morte por câncer entre as mulheres no mundo, sendo responsável por aproximadamente 570.000 novos casos e 311.000 mortes em 2018. O objetivo do presente artigo é identificar informações recentes e relevantes disponíveis na literatura sobre prevenção e rastreo do CCU. Trata-se de uma revisão integrativa com artigos datados entre 2018 a 2013 nas bases de dados da Lilacs, Scielo e Google Scholar. A vacinação contra o (HPV) é uma importante estratégia de saúde pública para prevenir o CCU. A vacina oferece uma ferramenta poderosa para reduzir substancialmente a carga de CCU ao nível mundial. O princípio fundamental do rastreio do câncer é a detecção da doença numa fase precoce curável na população assintomática e aparentemente saudável. O objetivo do rastreio do câncer de útero é detectar lesões de alto grau nas mulheres assintomáticas, tratá-las e prevenir a progressão para doença invasiva. Estratégias de prevenção e rastreamento são excelentes formas de atenuar a incidência e mortalidade de mulheres com CCU no mundo. No entanto, esses cuidados são menores em países socioeconomicamente desfavoráveis, mulheres negras e que moram em zonas rurais.Keywords
This publication has 12 references indexed in Scilit:
- Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?Laboratory Investigation, 2022
- Global distribution, risk factors, and recent trends for cervical cancer: A worldwide country-level analysisGynecologic Oncology, 2022
- Worldwide initiatives to eliminate cervical cancerInternational Journal of Gynecology & Obstetrics, 2021
- Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 yearsCancer, 2021
- Cervical cancer screening invitations in low and middle income countries: Evidence from ArmeniaSocial Science & Medicine, 2021
- MSCI: A multistate dataset for colposcopy image classification of cervical cancer screeningInternational Journal of Medical Informatics, 2021
- Towards the global elimination of cervical cancerPapillomavirus Research, 2019
- Too many women are dying from cervix cancer: Problems and solutionsGynecologic Oncology, 2018
- Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian studyVaccine, 2018
- Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and ReferralsAdvances in Therapy, 2018